Nov 12, 2024 04:05PM
Aug 8, 2024 04:05PM
May 15, 2024 04:05PM
Apr 12, 2024 06:00AM
Nov 9, 2023 07:00AM
Aug 10, 2023 07:00AM
May 11, 2023 08:00AM Oncocyte Reports First Quarter 2023 Financial Results
Mar 31, 2023 05:00PM
Nov 10, 2022 04:30PM
Aug 10, 2022 04:05PM
Jul 13, 2022 08:00AM
May 11, 2022 04:05PM
May 5, 2022 08:02AM
May 5, 2022 08:00AM Oncocyte Completes Validation of TheraSure™ Transplant Monitor Test
Mar 10, 2022 04:05PM
Dec 6, 2021 08:00AM
Nov 9, 2021 04:05PM
Sep 20, 2021 08:00AM
Aug 10, 2021 04:01PM
Jun 15, 2021 08:03AM
Jun 3, 2021 08:03AM OncoCyte (OCX) Announces Collaboration with Gruppo Oncologico del Nord Ovest to Evaluate Oncocyte’s DetermaIO Test in Colorectal Cancer, the Second Leading Cause of Cancer Mortality Globally
Jun 3, 2021 08:00AM
Jun 1, 2021 08:00AM
May 17, 2021 04:01PM
May 6, 2021 08:03AM
May 6, 2021 08:00AM
May 4, 2021 04:01PM
Apr 28, 2021 04:31PM Oncocyte to Present New Data on DetermaIO™ Test as a Predictor of Immunotherapy Response in Renal Cell Cancer at the 2021 ASCO Annual Meeting
Apr 19, 2021 08:00AM
Apr 14, 2021 09:02AM
Apr 10, 2021 01:31PM
Apr 6, 2021 04:05PM
Mar 16, 2021 04:01PM
Mar 16, 2021 08:10AM
Mar 16, 2021 08:00AM Oncocyte Announces Peer-Reviewed Publication of Data Assessing Use of DetermaIO™ to Identify Patients Likely to Benefit from Immunotherapy Across Multiple Tumor Types
Mar 15, 2021 08:00AM
Mar 9, 2021 08:00AM
Mar 4, 2021 08:07AM
Mar 4, 2021 08:00AM
Mar 3, 2021 04:01PM
Feb 25, 2021 08:00AM
Feb 9, 2021 04:05PM Oncocyte Announces Closing of $40 Million Public Offering of Common Stock
Feb 5, 2021 08:27AM
Feb 5, 2021 08:25AM
Feb 4, 2021 04:08PM
Feb 4, 2021 04:05PM
Feb 2, 2021 08:05AM
Feb 2, 2021 08:00AM
Jan 20, 2021 04:10PM OncoCyte (OCX) Announces Proposed $25M Registered Offering
Jan 20, 2021 04:08PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All